Sorted By:

Relevance


Medicare Monday: A guide to MedPAC’s Part D vote this week

PhRMA  |  Blog Post

Keep an eye on MedPAC activity later this week to see what happens with these draft recommendations.
http://catalyst.phrma.org/medicare-monday-a-guide-to-medpacs-part-d-vote-this-week

Many Say High Deductibles Make Their Health Law Insurance All but Useless

Access Better Coverage  |  From Our Network

In Newark, some plans have no deductible, although the median deductible is $2,000, according to HealthCare.gov.
http://www.accessbettercoverage.org/social-news/many-say-high-deductibles-make-their-health-law-insurance-all-but-useless

Director - Communications

PhRMA  |  PhRMA Career

We offer traditional (medical, dental, vision, flexible spending, life, AD&D, LTD, STD, LTC) and enhanced benefits such as parental leave, health advocate service, back-up childcare, commuting and financial & estate planning benefits.
https://www.phrma.org/careers/director-communications

PhRMA Statement on 2014 Special 301 Report

PhRMA  |  Press Release

Such a review provides a needed avenue for constructive engagement with the incoming Indian government on how to resolve the deteriorating IP environment in India
https://www.phrma.org/press-release/phrma-statement-on-2014-special-301-report

Vice President, Public Affairs

PhRMA  |  PhRMA Career

We offer traditional (medical, dental, vision, flexible spending, life, AD&D, LTD, STD, LTC) and enhanced benefits such as parental leave, health advocate service, back-up childcare, commuting and financial & estate planning benefits.
https://www.phrma.org

SWHR

PhRMA  |  Biography

Today, SWHR advocates for greater public and private funding for women’s health research and the study of biological differences that: Affects the prevention, diagnosis and treatment of disease; Encourages the appropriate inclusion of women and minorities in medical research studies; Promotes the analysis of research data for biological and ethnic differences; and Informs women, health care providers, and policy makers about contemporary women’s health issues through media outreach, congressional briefings, public education campaigns, conferences and special events.
https://www.phrma.org/biography/swhr

New Report Shows Minnesota Clinical Trials Benefit Patients, State Economy and Science

PhRMA  |  Press Release

Clinical research has been conducted at university medical schools, local hospitals, specialty treatment centers and contract research organizations in more than a dozen Minnesota communities. 
https://www.phrma.org/press-release/new-report-shows-minnesota-clinical-trials-benefit-patients-state-economy-and-science

Research in Minnesota

PhRMA  |  Research In Your Backyard

The trials have been aimed at a wide array of diseases and medical conditions, ranging from the most debilitating chronic diseases, including cancer, pain, heart disease, obesity and diabetes, to bothersome allergies, sinusitis, chronic obstructive pulmonary disease (COPD), migraine headaches, pneumonia and rare diseases affecting small patient populations.
https://www.phrma.org/research-in-your-backyard/research-in-minnesota

PhRMA Applauds 2015 We Work For Health Champion Award Winners

PhRMA  |  Press Release

About We Work for Health We Work For Health is a grassroots initiative that shows how biopharmaceutical research and medical innovation work together to create a strong, vibrant economy and a healthier America.
https://www.phrma.org/press-release/phrma-applauds-2015-we-work-for-health-champion-award-winners

Biopharmaceutical Companies Recognized as Meaningful Places to Work

PhRMA  |  Blog Post

According to Business Insider the scores were calculated considering “high job satisfaction, low job stress, ability to telecommute, high job meaning, experienced median pay/total cash compensation, and salary delta.”
http://catalyst.phrma.org/biopharmaceutical-companies-recognized-as-meaningful-places-to-work

New Blood Tests, Liquid Biopsies, May Transform Cancer Care

From Hope To Cures  |  From Our Network

"I think it's wonderful," said Bedi, who lives in Atlanta and goes to Houston for his care.
http://www.fromhopetocures.org/new-blood-tests-liquid-biopsies-may-transform-cancer-care

ICYMI: New Study Highlights Often High Out-of-Pocket Costs in Exchanges

PhRMA  |  Blog Post

It’s important for patients to be aware of how their plan deductible is structured.
http://catalyst.phrma.org/icymi-new-study-highlights-often-high-out-of-pocket-costs-in-exchanges

Stopping Ebola

PhRMA  |  From PhRMA

WHO on Ebola CDC on Ebola NIH on Ebola IFPMA on Ebola RxResponse on Ebola White House Response to Ebola IFPMA: Ebola Capacity Building Page EFPIA & IMI Announce Collaborative Efforts Against Ebola Ebola virus disease (EVD), formerly known as Ebola haemorrhagic fever, is a severe, often fatal illness in humans.
https://www.phrma.org/science/how-far-we-ve-come/progress-in-treating-disease/stopping-ebola

Week in Review: The Latest from PhRMA

PhRMA  |  Blog Post

Smith, principal, RIS Consulting and past executive vice president for Policy and Research at PhRMA, shed light on the Medicare Payment Advisory Commission’s (MedPAC) discussion about drug spending in Medicare in a special “Medicare Monday” series: Part I: Smith reveals that prescription medicines’ share of Medicare spending was nearly the same in 2007 and 2013, even as many important advances in medicines reached patients.
http://catalyst.phrma.org/week-in-review-the-latest-from-phrma-october-9-2015

Medicare Monday: 3 things to know about Medicare Part B

PhRMA  |  Blog Post

Check back in the coming weeks for more on Medicare Part B and follow our hashtag on Twitter at #MedicareMonday.Click to edit your new post...
http://catalyst.phrma.org/medicare-monday-3-things-to-know-about-medicare-part-b

Week in Review: The latest from PhRMA

PhRMA  |  Blog Post

Communications with health care professionals – .netdna-ssl.com/client_assets/dwonk/media/attachments/56c6/61b7/6970/2d57/02bf/0000/56c661b769702d5702bf0000.pdf?
http://catalyst.phrma.org/week-in-review-the-latest-from-phrma-march-4-2016

Nearly 450 Innovative Medicines in Development For Neurological Disorders

PhRMA  |  Press Release

The Medicines in Development for Neurological Disorders report and other supplementary materials are available on PhRMA’s website at http://phrma.org/innovation/meds-in-development   The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research and biotechnology companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives.
https://www.phrma.org/press-release/nearly-450-innovative-medicines-in-development-for-neurological-disorders

ICYMI – 3 new reports show dramatic slowdown in medicine spending growth

PhRMA  |  Blog Post

These trend reports follow a recent analysis by the Berkeley Research Group which found brand biopharmaceutical companies retained just 63 percent of total gross (based on list price) spending on brand medicines.
http://catalyst.phrma.org/icymi-3-new-reports-show-dramatic-slowdown-in-medicine-spending-growth

B Vitamin Is Found to Help People Prone to Some Types of Skin Cancer

From Hope To Cures  |  From Our Network

Those who received the experimental drug, called elotuzumab, had a median of 19.4 months before their cancer worsened or they died, compared with 14.9 months for those who received only the two existing drugs, Revlimid and dexamethasone.
http://www.fromhopetocures.org/b-vitamin-is-found-to-help-people-prone-to-some-types-of-skin-cancer

Matt Bennett Joins PhRMA as Senior VP, Communications

PhRMA  |  Press Release

Previously, Bennett managed policy affairs on telecommunications issues for the Alliance for Public Technology, and coordinated media and external relations activities for the Alliance for Community Media.
https://www.phrma.org/press-release/matt-bennett-joins-phrma-as-senior-vp-communications

Medicare Monday: A Medicare Part D reading list

PhRMA  |  Blog Post

What they are saying about MedPAC’s recommendations, as well as a closer look at the recommendations Why Part D Extra Help matters for patients like Mateo and Diane What actually happened with Medicare Part D in the first 10 years of the program Learn more at PhRMA.org/PartD, and sign up for regular updates here.
http://catalyst.phrma.org/medicare-monday-a-medicare-part-d-reading-list

The Challenge of Diagnosing Alzheimer's Disease

PhRMA  |  Blog Post

It is interesting history and a reminder of how important it is that we do all we can to develop both more effective treatments and diagnostic tools.
http://catalyst.phrma.org/the-challenge-of-diagnosing-alzheimers-disease

Building on the promise of personalized medicine

PhRMA  |  Blog Post

Bernie Zeiher, president of development of Astellas, discusses his excitement around the promise of personalized medicine, which uses diagnostic tools to help assess the medical treatments and procedures that may be best for each patient.
http://catalyst.phrma.org/building-on-the-promise-of-personalized-medicine

PhRMA Statement on Patent Settlements

PhRMA  |  Press Release

PhRMA believes that each settlement between a brand and generic should be judged on its own merit, taking all the facts into account, and the FTC, Department of Justice and the courts are well-equipped to evaluate individual settlements and determine whether they will help or hurt consumers.”
https://www.phrma.org/press-release/phrma-statement-on-patent-settlements1

Rick Dunetz

PhRMA  |  Biography

Coach D has numerous coaching certifications to include Gold Medal Squared, Sports Performance and CAP I.
https://www.phrma.org/biography/rick-dunetz

You have reviewed the first 250 results out of 1044. Each page contains 25 results. You're on page 10.

prev 7 8 9 10 11 12 next